iShares US Pharmaceuticals ETF
IHE
IHE
95 hedge funds and large institutions have $79M invested in iShares US Pharmaceuticals ETF in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 28 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $83.8M → $79M (-$4.79M)
21% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 28
Holders
95
Holding in Top 10
–
Calls
$728K
Puts
$3K
Top Buyers
| 1 | +$3.67M | |
| 2 | +$1.09M | |
| 3 | +$571K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$505K |
| 5 |
FTUS
Flow Traders U.S.
New York
|
+$391K |
Top Sellers
| 1 | -$5.21M | |
| 2 | -$5.19M | |
| 3 | -$1.15M | |
| 4 |
SRSA
S.R. Schill & Associates
Mercer Island,
Washington
|
-$990K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$963K |